Use of FGF21 analogs for the treatment of metabolic disorders: a systematic review and meta-analysis
ABSTRACT FGF21 is a hormone produced primarily by the liver with several metabolic functions, such as induction of heat production, control of glucose homeostasis, and regulation of blood lipid levels. Due to these actions, several laboratories have developed FGF21 analogs to treat patients with met...
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
Brazilian Society of Endocrinology and Metabolism
2023-11-01
|
| Saila: | Archives of Endocrinology and Metabolism |
| Gaiak: | |
| Sarrera elektronikoa: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972024000100701&tlng=en |